The National Academy of Medicine has named an international committee to assess how COVID-19 vaccine development and other policies could facilitate global efforts to prepare for seasonal flu and a flu pandemic.

As part of the initiative, the Department of Health and Human Services has asked the National Academies of Sciences, Engineering, and Medicine to release consensus reports this fall on vaccine research and development; vaccine distribution and supply chains; public health interventions and countermeasures; and global coordination, partnerships and financing.

NAM will host a public workshop this spring to hear from experts and gather feedback to inform the reports.

Related News Articles

Blog
Understanding potential costs is an important part of the patient experience when planning for care, and hospitals and health systems are committed to helping…
Headline
An initial 10 million doses of COVID-19 vaccine are available for children under age 5 if the Food and Drug Administration authorizes and the Centers for…
Headline
The Centers for Disease Control and Prevention late Friday issued recommendations for clinicians testing or treating patients for H5N1 bird flu. CDC Thursday…
Headline
The Centers for Disease Control and Prevention last night confirmed a case of H5N1 bird flu in someone exposed to infected poultry in Colorado. This is the…
Headline
The Centers for Disease Control and Prevention yesterday broadened its masking guidance, enabling visitors of health care facilities to wear N95 masks.…
Headline
Pfizer yesterday asked the Food and Drug Administration to authorize a second booster dose of its COVID-19 vaccine for adults age 65 and older who…